Can vitamins or supplements improve eczema?
For atopic dermatitis, no vitamin or supplement is a proven universal treatment or cure. Some trials and reviews report possible improvements with particular products, but results vary according to the nutrient, formulation, population studied, and duration of treatment. The evidence does not support replacing established eczema care with supplements.
The available research also has important limitations. A Cochrane review found no convincing benefit from the dietary supplements it evaluated for established atopic eczema, noting that studies were often small, varied substantially, or had methodological limitations. The American Academy of Dermatology likewise concluded that evidence was inconsistent or insufficient to recommend routine use of the dietary supplements it reviewed.
A low nutrient level and a response to supplementation are separate questions. People with atopic dermatitis may have lower levels of a nutrient in some studies, but that does not show that the deficiency caused the skin disease. It also does not establish that taking the nutrient will improve eczema unless a relevant deficiency is confirmed and treatment is appropriate.
Treatment research should not be confused with prevention research. Studies of supplements taken during pregnancy or infancy may address the later development of atopic dermatitis, whereas this article focuses on treating people who already have the condition. Findings from one age group or purpose cannot automatically be applied to another.
Vitamin D and eczema
Vitamin D is one of the more extensively studied supplements for atopic dermatitis. A 2024 systematic review and meta-analysis of randomized trials found that oral vitamin D supplementation reduced atopic dermatitis severity scores compared with control. The studies differed in their participants, treatment regimens, and duration. The findings suggest possible benefit but do not establish a universal treatment plan or guarantee that vitamin D will help every person.
Vitamin D status and eczema treatment response are not interchangeable concepts. A person may have a low vitamin D level without knowing whether correcting it will change their skin symptoms. A study showing an average improvement across a group does not mean that everyone in the group benefited or that the same result applies to every product and dose.
Testing and supplementation decisions should be individualized, particularly for children and for anyone considering high-dose products. A clinician can consider dietary intake, health conditions, existing medicines, and whether testing is appropriate. The amounts and schedules used in research should not be copied as self-treatment instructions.
Vitamin D should be viewed as a possible adjunct, not a replacement for moisturization or clinician-directed treatment. If eczema symptoms continue, relying on a supplement alone may delay care that is better supported for controlling established atopic dermatitis.
Supplementary Eczema Questions
Vitamin E, zinc and other micronutrients
Evidence for vitamin E is limited. One small randomized trial in people with mild-to-moderate atopic dermatitis reported improved eczema outcomes with oral vitamin E compared with placebo. A single small study, however, cannot establish routine effectiveness, determine which patients might benefit, or provide a general dosing recommendation.
Zinc is important for normal biological processes, including those involved in skin health. A systematic review found that people with atopic dermatitis had lower zinc levels than controls in the studies examined. This association does not prove that low zinc causes atopic dermatitis. It also does not show that zinc supplements will improve eczema when a deficiency has not been demonstrated. Evidence from intervention studies remains limited and inconsistent.
Other micronutrients, including vitamins B6 and B12, are sometimes promoted for skin symptoms, but reliable evidence for treating established atopic dermatitis is sparse. Oral supplements should also be distinguished from topical products containing vitamins or other ingredients; evidence for one form cannot automatically be applied to another.
When a deficiency is suspected, the sensible question is whether it should be evaluated and treated under professional guidance. Taking several micronutrients indiscriminately can add unnecessary exposure and make it harder to identify what is helping or causing unwanted effects.
Probiotics, prebiotics and synbiotics
Probiotics are live microorganisms intended to provide a health effect when consumed. Prebiotics are substances used by microorganisms, while synbiotics combine probiotics and prebiotics. These terms describe different types of products and should not be treated as interchangeable.
Research on probiotics for established atopic dermatitis has produced variable results. A meta-analysis of randomized trials in children found an overall reduction in severity, but the findings differed according to age and intervention. Probiotic effects may depend on the strain, formulation, combination of organisms, study population, treatment duration, and outcome being measured. A product marketed for general digestive health cannot be assumed to reproduce the results of a particular research product.
There is therefore no universally effective probiotic strain, dose, or treatment duration established for eczema. Results in children should not automatically be applied to adults, and findings from one combination should not be generalized to all probiotic or synbiotic products.
Prevention research is a separate issue. A study examining whether an intervention affects the later development of atopic dermatitis in infants does not establish that the same intervention treats someone who already has the condition. Children, in particular, should not be given probiotics or other supplements for eczema without discussing the product with a clinician.
Fish oil, evening primrose oil and borage oil
These oils are often grouped together, but their evidence is not identical. Fish-oil supplements have been studied for eczema, yet the evidence remains limited and uncertain. Plausible anti-inflammatory effects do not by themselves establish that a product improves symptoms in everyday clinical use.
Evidence for evening primrose oil and borage oil is less encouraging. A Cochrane review of 27 studies found no clinically useful improvement in eczema compared with placebo for either oil. The studies also did not establish long-term safety. A product's plant origin or fatty-acid content should not be taken as evidence that it will control atopic dermatitis.
The exact oil, preparation, concentration, and combination of ingredients matter when considering a product. Products sold under the same broad name may not be identical to those used in research. Findings for one formulation cannot automatically be transferred to another.
Oils and other supplements can also produce adverse effects or raise medication-related questions. The relevant safety issues depend on the specific product and a person's medicines and health conditions. A clinician or pharmacist can review the exact label and medication list before use, especially when a child is involved or when several supplements are being considered.
Melatonin and other emerging supplements
Melatonin is an emerging, population-specific option rather than a standard supplement for atopic dermatitis. In a randomized crossover trial involving children and adolescents with atopic dermatitis and sleep disturbance, melatonin improved sleep-onset time and reduced eczema severity during the studied treatment periods. The trial does not establish routine use, long-term safety, or effectiveness in adults.
The study's age group, clinical features, and short treatment periods limit how broadly the findings can be applied. A pediatric result should not be used to create a recommendation for adults, and the research dose should not be copied as a general instruction. Any consideration of melatonin for a child requires discussion with a clinician.
Other products, including vitamin C, curcumin, oral ceramides, and similar emerging supplements, are also promoted for skin health. Current evidence is not sufficient to establish them as reliable treatments for atopic dermatitis. Biological plausibility or an early study may justify further research, but it is not the same as proof of clinical benefit.
For emerging products, the main questions are whether the evidence involves people with established atopic dermatitis, whether the product matches the one studied, and whether benefits and safety have been evaluated for the intended age group. Until those questions are answered, these products should remain optional and carefully considered rather than routine treatment.
Supplement safety and choosing a sensible approach
Before starting a supplement, first confirm that the skin problem is atopic dermatitis or another condition for which the product is being considered. Different skin disorders can resemble eczema, and a supplement aimed at atopic dermatitis may not address the actual diagnosis. Define the goal: correcting a documented deficiency is different from taking a supplement specifically to reduce eczema symptoms.
A clinician or pharmacist can review:
- all prescription and nonprescription medicines;
- current vitamins, herbal products, and other supplements;
- relevant health conditions;
- whether a deficiency risk is present and whether evaluation is appropriate;
- the product's ingredients, formulation, and intended use.
Extra caution is appropriate for children, pregnancy or breastfeeding, chronic illness, and concurrent medication use. The American Academy of Dermatology advises discussing supplements with a dermatologist before giving them to a child with eczema because effectiveness may be limited, pediatric safety information may be sparse, adverse effects can occur, and some supplements can interact with medicines.
Products with the same broad ingredient may differ in chemical form, concentration, strain, combination, and manufacturing quality. A retail product therefore may not match the product tested in a clinical study. Avoid megadosing and avoid combining several products that contain overlapping ingredients. Professional guidance is particularly important when a supplement is being considered as an alternative to treatment with stronger evidence.
Where supplements fit in an eczema treatment plan
Supplements are optional adjuncts, not replacements for moisturization, trigger management, or clinician-directed anti-inflammatory treatment. Moisturizers are a cornerstone of atopic dermatitis therapy, and abandoning established skin care while trying a supplement can leave inflammation insufficiently controlled.
If a clinician agrees that a supplement trial is reasonable, define one target outcome in advance. The goal might be a change in itch, sleep, flare frequency, or another symptom, depending on the person's situation. Changing several treatments at the same time makes it difficult to know what caused an improvement, lack of benefit, or adverse effect. Reassessment with the clinician can help determine whether continuing the product is sensible.
A supplement should not be used to postpone medical assessment when eczema is worsening, extensive, difficult to control, or not responding to treatment. Possible infection also requires medical attention rather than escalation of supplements.
The overall evidence supports a cautious, individualized approach. Some products, including vitamin D, probiotics in selected pediatric studies, vitamin E in a small trial, and melatonin in a specific pediatric study, show possible benefits under particular conditions. That evidence is not proof of a cure or identification of one best vitamin or supplement for everyone.